famotidine has been researched along with n-vinyl-2-pyrrolidinone in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Badawy, SI; Gray, DB; Hussain, MA; Schuster, AE; Sun, D; Zhao, F | 1 |
Jaimini, M; Rana, AC; Tanwar, YS | 1 |
Marek, T; Süvegh, K; Szente, V; Zelkó, R | 1 |
Abou-Taleb, AE; Hirayama, F; Iohara, D; Ishiguro, T; Khaled, KA; Mady, FM; Otagiri, M; Uekama, K; Yamasaki, K | 1 |
Bharathi, K; Kaza, R; Nagaraju, R; Prathusha, AP; Subhash Chandra Bose, P | 1 |
Brettmann, BK; Cheng, K; Myerson, AS; Trout, BL | 1 |
Jiang, Y; Qi, X; Wu, Z; Zhang, H | 1 |
7 other study(ies) available for famotidine and n-vinyl-2-pyrrolidinone
Article | Year |
---|---|
Formulation of solid dosage forms to overcome gastric pH interaction of the factor Xa inhibitor, BMS-561389.
Topics: Animals; Biological Availability; Chemistry, Pharmaceutical; Dogs; Drug Interactions; Excipients; Factor Xa Inhibitors; Famotidine; Gastric Acid; Gastrointestinal Agents; Gastrointestinal Tract; Histamine H2 Antagonists; Hydrogen-Ion Concentration; Intestinal Absorption; Isoxazoles; Pentagastrin; Povidone; Pyrazoles; Solubility; Tablets | 2006 |
Formulation and evaluation of famotidine floating tablets.
Topics: Anti-Ulcer Agents; Bioreactors; Carbon Dioxide; Chemistry, Pharmaceutical; Citric Acid; Drug Delivery Systems; Famotidine; Gels; Hardness; Hydrogen-Ion Concentration; Methylcellulose; Molecular Weight; Povidone; Reproducibility of Results; Rheology; Sodium Bicarbonate; Stearic Acids; Surface Properties; Tablets; Talc; Time Factors; Viscosity | 2007 |
Prediction of the stability of polymeric matrix tablets containing famotidine from the positron annihilation lifetime distributions of their physical mixtures.
Topics: Acrylates; Algorithms; Drug Stability; Drug Storage; Electrons; Excipients; Famotidine; Forecasting; Histamine H2 Antagonists; Polymers; Povidone; Solubility; Tablets | 2009 |
Enhancement of the aqueous solubility and masking the bitter taste of famotidine using drug/SBE-beta-CyD/povidone K30 complexation approach.
Topics: beta-Cyclodextrins; Famotidine; Humans; Povidone; Solubility; Taste; Water; X-Ray Diffraction | 2010 |
Preparation and evaluation of famotidine polymorphs.
Topics: Animals; Anti-Ulcer Agents; Crystallization; Disease Models, Animal; Drug Stability; Excipients; Famotidine; Female; Kinetics; Male; Povidone; Rats; Rats, Wistar; Solubility; Solvents; Stomach Ulcer | 2010 |
Electrospun formulations containing crystalline active pharmaceutical ingredients.
Topics: Albendazole; Anti-Ulcer Agents; Antiparasitic Agents; Chemistry, Pharmaceutical; Crystallization; Equipment Design; Famotidine; Nanofibers; Particle Size; Povidone; Solubility; Tablets; X-Ray Diffraction | 2013 |
Tablets compressed with gastric floating pellets coated with acrylic resin for gastro retention and sustained release of famotidine: in-vitro and in-vivo study.
Topics: Acrylic Resins; Administration, Oral; Animals; Area Under Curve; Biological Availability; Cellulose; Delayed-Action Preparations; Drug Delivery Systems; Excipients; Famotidine; Hydrochloric Acid; Intestinal Absorption; Polymethacrylic Acids; Povidone; Pressure; Rats, Sprague-Dawley; Stomach; Tablets | 2015 |